Skip to main content
SpringerLink
Log in

Most of the new regulations stemming from Bill 102, the Transparent Drug System for Patients Act 2006, previously approved by the Ontario government in Canada, will soon come into effect,

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Ontario's Bill 102 will shape pharma reforms, reimbursement across Canada. Marketletter: Pharma News Daily: [2 pages], 1 Sep 2006. Available from: URL: http://www.marketletter.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Most of the new regulations stemming from Bill 102, the Transparent Drug System for Patients Act 2006, previously approved by the Ontario government in Canada, will soon come into effect,. Pharmacoecon. Outcomes News 511, 10 (2006). https://doi.org/10.2165/00151234-200605110-00026

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200605110-00026

Keywords

Search

Navigation